Investigation of the Adequacy of 100 IU/Kg Unfractionated Heparin Loading Dose by Activated Clotting Time In Children With Congenital Heart Disease During Cardiac Catheterization
Öz
Purpose: This study investigated whether an activated clotting time (ACT) between 200 and 300 sec could be achieved with a100 IU/kg unfractionated heparin (UHF) loading dose in patients with congenital heart disease (CHD) during pediatric cardiac catheterization.
Materials and Methods: We included 264 patients aged 0-18 years with CHD undergoing cardiac catheterization between January 2022-March 2023. Data on patient characteristics, UHF doses, and ACT values were retrospectively obtained. The patients were intravenously administered 100 IU/kg UFH after sheath placement. We aimed to obtain a value between 200 and 300 sec according to the ACT measured at the 5th minute. If the measured ACT value at the 5th min was < 200 sec, additional heparin doses between 20 and 50 IU/kg were administered such that the total heparin loading dose did not exceed 150 IU/kg. Patients were divided into two groups based on whether the ACT value was below or above 200 sec.
Results: Median age, weight, and ACT value at procedure were 6.41(IQR:2.01–32.21) months, 6.13(IQR:3.79-11.9) kg, and 212(IQR:190-240) sec, respectively. The ACT value of 170(64.4%) of the 264 patients was between 200-300 sec, which was considered the target value. The ACT value of 86(32.6%) of the 264 patients was below the target value and that of eight (3%) patients was above the target value. Hematoma occurred at the access site in four patients (1.5%). We did not detect retroperitoneal hematoma, other bleedings at location, or thromboembolism in any of the patients. No significant differences were observed in comparisons between age subgroups and ACT distribution, or between age subgroups and ACT subgroups (p>0.05)
Conclusion: This study revealed that a 100 IU/kg UFH loading dose produced the target ACT value in 64.4% of the patients and that the UFH loading dose should be individualized according to the ACT value in the remaining patients.
Anahtar Kelimeler
congenital heart disease, Cardiac catheterization, Unfractionated heparin, Activated clotting time
Destekleyen Kurum
Baskent University
Proje Numarası
KA23/188
Kaynakça
- Kim GG, El Rouby S, Thompson J, Gupta A, Williams J, Jobes DR. Monitoring unfractionated heparin in pediatric patients with congenital heart disease having cardiac catheterization or cardiac surgery. J Thromb Thrombolysis 2010; 29:429-436
- Grady RM, Eisenberg PR, Bridges ND. Rational approach to use of heparin during cardiac catheterization in children. J Am Coll Cardiol1995; 25:725-729
- Gottlieb EA, Andropoulos DB. Current and future trends in coagulation management for congenital heart surgery. J Thorac Cardiovasc Surg 2017; 153:1511-1515
- Muster I, Haas T, Quandt D, Kretschmar O, Knirsch W. Factors influencing ACT after intravenous bolus administration of 100 IU/kg of unfractionated heparin during cardiac catheterization in children. Clin Appl Thromb Hemost 2017; 23:740-747
- Saxena A, Gupta R, Kumar RK, Kothari SS, Wasir HS. Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Cathet Cardiovasc Diagn1997; 4:400˗403
- Bulbul ZR, Galal MO, Mahmoud E, Narden B, Solymar L, Chaudhary MA, et al. Arterial complications following cardiac catheterization in children less than 10 kg. Asian Cardiovasc Thorac Ann 2002; 10:129˗132
- Bansal N, Misra A, Forbes TJ, Kobayashi D. Femoral artery thrombosis after pediatric cardiac catheterization. Pediatr Cardiol 2021; 42:753˗761
- Hanslik A, Kitzmüller E, Thom K, Haumar M, Mlekusch W, Salzer-Muhar U, et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high-dose vs. low-dose heparin protocols. J Thromb Haemost 2011; 9:2353-2360
- Chen D, Långström S, Petäjä J, Heikinheimo M, Pihkala J. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization. Catheter Cardiovasc Interv 2013; 81:1174-1179
- Glatz AC, Shah SS, McCarthy AL, Geisser D, Daniels K, Xie D, et al. Prevalence of and risk factors for acute occlusive arterial injury following pediatric cardiac catheterization: a large single˗center cohort study. Catheter Cardiovasc Interv 2013; 82:454˗462